more clinical testing would be carried out between 2008 until 2010

The drug company Sanofi Aventis is continuing to test and collect clinical data for the diet drug Acomplia. This is in response to the new Food and Drug Administration ruling that they were concerned that the weight loss medication may cause depressive tendencies in some people that use it. The head of the company Mr. Hanspeter Spek said that lots more clinical testing would be carried out between 2008 until 2010 which they hoped would show the Food and Drug Administration that the drug is perfectly safe.

While the Food and Drug Administration ruled that the Acomplia weight loss drug should not be given an approval for sale and marketing in America they did nevertheless say that they were ready to look at the clinical data again when more testing had been done. The Acomplia weight loss drug is considered to be one of the most effective diet medications on the market today and is being taken by tens of thousands of individuals in Europe and in other nations around the world. The EMEA which is the European Union health authority has given full approval for Acomplia and has tested it extremely thoroughly.

Many people think that the FDA did not give approval for Acomplia because of the litigation culture in America which could mean that they could be sued if they gave approval for it. At Ukmedix News while we respect the FDA decision we feel that the drug is safe and should be on sale. If you have a medical history of depression you shouldn't use the Acomplia weight loss drug but use some other medication like Reductil or Xenical Just to be on the safe side.

Acomplia is a prescription medication that should only be used after speaking to a doctor and giving him your full medical history. Acomplia is also thought if to help diabetics with their blood sugar levels.